Mapping tumor vascular diversity by screening phage display libraries

Journal of Controlled Release

Volumn 91, Issue 1-2, 2003, Pages 183-186

  Zurita, Amado J ^a   Arap, Wadih ^a   Pasqualini, Renata ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Phage display; Targeting peptides; Therapeutic targeting; Vascular heterogeneity; Vascular targeting

Indexed keywords

BLOOD VESSELS; IMAGING TECHNIQUES; PROTEINS;

PHAGE DISPLAY LIBRARIES;

TUMORS;

CYTOKINE; CYTOTOXIC AGENT; PEPTIDE LIBRARY; PROTEINASE INHIBITOR; RECOMBINANT DNA; ANGIOGENESIS INHIBITOR; CELL SURFACE RECEPTOR;

ANGIOGENESIS; CARCINOGENESIS; CELL SURFACE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DNA VECTOR; DRUG EFFICACY; DRUG TARGETING; GENE THERAPY; GENETIC VARIABILITY; HUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; TUMOR GROWTH; VASCULARIZATION; ANIMAL; BLOOD FLOW; BLOOD VESSEL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; NEOPLASM; REVIEW;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; HUMANS; NEOPLASMS; PEPTIDE LIBRARY; RECEPTORS, CELL SURFACE; REGIONAL BLOOD FLOW;

EID: 0141990618     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00236-0     Document Type: Conference Paper

References (27)

1. Pasqualini R., Arap W. Vascular targeting. Bertino J.R. 2nd Edition Encyclopedia of Cancer. Vol. 4:2002;501-507 Academic Press/Elsevier, San Diego, CA.
2. Folkman J. Tumor angiogenesis. Holland J.F., Frei E. Cancer Medicine. 2000;132-152 B.C. Decker, Hamilton.
3. McDonald D.M., Foss A.J.E. Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev. 19:2000;109-120.
4. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K., McDonald D.M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156:2000;1363-1380.
5. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
6. Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 380:1996;364-366.
7. Rajotte D., Arap W., Hagedorn M., Koivunen E., Pasqualini R., Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102:1998;430-437.
8. Pasqualini R., Koivunen E., Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 15:1997;542-546.
9. Burg M.A., Pasqualini R., Arap W., Ruoslahti E., Stallcup W.B. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res. 59:1999;2869-2874.
10. Pasqualini R., Koivunen E., Kain R., Lahdenranta J., Sakamoto M., Stryhn A., Ashmun R.A., Shapiro L.H., Arap W., Ruoslahti E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60:2000;722-727.
11. Essler M., Ruoslahti E. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc. Natl. Acad. Sci. USA. 99:2002;2252-2257.
12. Arap W., Haedicke W., Bernasconi M., Kain R., Rajotte D., Krajewski S., Ellerby H.M., Bredesen D.E., Pasqualini R., Ruoslahti E. Targeting the prostate for destruction through a vascular address. Proc. Natl. Acad. Sci. USA. 99:2002;1527-1531.
13. Laakkonen P., Porkka K., Hoffman J.A., Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8:2002;751-755.
14. St. Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science. 289:2000;1197-1202.
15. Liotta L., Petricoin E. Molecular profiling of human cancer. Nat. Rev. Genet. 1:2000;48-56.
16. Carson-Walter E.B., Watkins D.N., Nanda A., Vogelstein B., Kinzler K.W., St. Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 61:2001;6649-6655.
17. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
18. Giordano R.J., Cardó-Vila M., Lahdenranta J., Pasqualini R., Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 7:2001;1249-1253.
19. Arap W., Pasqualini R., Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:1998;377-380.
20. Kolonin M.G., Pasqualini R., Arap W. Teratogenicity induced by targeting a placental immunoglobulin transporter. Proc. Natl. Acad. Sci. USA. 99:2002;13055-13060.
21. Arap W., Kolonin M.G., Trepel M., Lahdenranta J., Cardó-Vila M., Giordano R.J., Mintz P.J., Ardelt P.U., Yao V.J., Vidal C.I., Chen L., Flamm A., Valtanen H., Weavind L.M., Hicks M.E., Pollock R.E., Botz G.H., Bucana C.D., Koivunen E., Cahill D., Troncoso P., Baggerly K.A., Pentz R.D., Do K.A., Logothetis C.J., Pasqualini R. Steps toward mapping the human vasculature by phage display. Nat. Med. 8:2002;121-127.
22. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D., Krajewski S., Lombardo C.R., Rao R., Ruoslahti E., Bredesen D.E., Pasqualini R. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med. 5:1999;1032-1038.
23. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O.P., Heikkilä P., Kantor C., Gahmberg C.G., Salo T., Konttinen Y.T., Sorsa T., Ruoslahti E., Pasqualini R. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17:1999;768-774.
24. Curnis F., Sacchi A., Borgna L., Magni F., Gasparri A., Corti A. Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat. Biotechnol. 18:2000;1185-1190.
25. Hong F.D., Clayman G.L. Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. Cancer Res. 60:2000;6551-6556.
26. Chen Y., Xu X., Hong S., Chen J., Liu N., Underhill C.B., Creswell K., Zhang L. RGD-tachyplesin inhibits tumor growth. Cancer Res. 61:2001;2434-2438.
27. Trepel M., Grifman M., Weitzman M.D., Pasqualini R. Molecular adaptors for vascular-targeted adenoviral gene delivery. Hum. Gene Ther. 11:2000;1971-1981.